UPDATE: Oppenheimer Initiates Coverage on Envision Healthcare on Premier Operator Position

Loading...
Loading...
In a report published Monday, Oppenheimer analyst Michael Wiederhorn initiated coverage on
Envision Healthcare HoldingsEVHC
with an Outperform rating and $33.00 price target. In the report, Oppenheimer noted, “We are initiating coverage of Envision Healthcare with an Outperform rating and a $33 price target, or 18% upside from current levels. In our view, Envision is the premier operator in two highly fragmented industries through its two subsidiaries: EmCare in the hospital-based physician outsourcing business and American Medical Response (AMR) in the emergency transport market. Overall, this is a compelling growth story, with favorable pricing power, a promising M&A opportunity, significant upside from its new Evolution Health business and a proven management team. Furthermore, with ~20% of volumes from self-pay sources, Envision is uniquely positioned to benefit from the Affordable Care Act's coverage benefits between 2014 and 2016.” Envision Healthcare Holdings closed on Friday at $26.84.
Posted In: Analyst ColorInitiationAnalyst RatingsMichael WiederhornOppenheimer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...